Andreas Moan

1.0k total citations
31 papers, 868 citations indexed

About

Andreas Moan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Andreas Moan has authored 31 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Physiology. Recurrent topics in Andreas Moan's work include Heart Rate Variability and Autonomic Control (15 papers), Blood Pressure and Hypertension Studies (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Andreas Moan is often cited by papers focused on Heart Rate Variability and Autonomic Control (15 papers), Blood Pressure and Hypertension Studies (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Andreas Moan collaborates with scholars based in Norway, United States and Sweden. Andreas Moan's co-authors include Sverre E. Kjeldsen, Gudmund Nordby, Aud Høieggen, Eigil Fossum, Morten Rostrup, Ingrid Os, Ivar Eide, SE Kjeldsen, Harald Arnesen and Kåre I. Birkeland and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Hypertension.

In The Last Decade

Andreas Moan

30 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Moan Norway 18 541 345 177 143 101 31 868
Francesca Arenare Italy 12 809 1.5× 163 0.5× 173 1.0× 67 0.5× 80 0.8× 18 1.0k
Elena Cerquetani Italy 13 311 0.6× 420 1.2× 72 0.4× 75 0.5× 81 0.8× 29 941
Eiji Gotoh Japan 18 622 1.1× 263 0.8× 122 0.7× 69 0.5× 105 1.0× 79 1.1k
Ciro Basile Fasolo Italy 6 592 1.1× 178 0.5× 438 2.5× 75 0.5× 144 1.4× 8 988
J. I. M. Drayer United States 16 781 1.4× 249 0.7× 59 0.3× 89 0.6× 97 1.0× 32 1.1k
SE Kjeldsen Norway 13 454 0.8× 186 0.5× 69 0.4× 41 0.3× 56 0.6× 32 681
Thomas Makris Greece 19 390 0.7× 148 0.4× 135 0.8× 63 0.4× 22 0.2× 41 813
H. Steinberg United States 9 215 0.4× 272 0.8× 209 1.2× 29 0.2× 68 0.7× 10 670
A. C. Pessina Italy 17 390 0.7× 443 1.3× 91 0.5× 77 0.5× 42 0.4× 39 1.0k
P. Lazzari Italy 15 704 1.3× 324 0.9× 68 0.4× 34 0.2× 38 0.4× 30 903

Countries citing papers authored by Andreas Moan

Since Specialization
Citations

This map shows the geographic impact of Andreas Moan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Moan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Moan more than expected).

Fields of papers citing papers by Andreas Moan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Moan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Moan. The network helps show where Andreas Moan may publish in the future.

Co-authorship network of co-authors of Andreas Moan

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Moan. A scholar is included among the top collaborators of Andreas Moan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Moan. Andreas Moan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aksnes, Tonje A., Ingebjørg Seljeflot, Peter A. Torjesen, et al.. (2007). Improved insulin sensitivity by the angiotensin II–receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity. Metabolism. 56(11). 1470–1477. 26 indexed citations
2.
Aksnes, Tonje A., Henrik M. Reims, Soneil Guptha, et al.. (2006). Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. Journal of Human Hypertension. 20(11). 860–866. 26 indexed citations
3.
Fossum, Eigil, Andreas Moan, Sverre E. Kjeldsen, et al.. (2005). The Effect of Losartan Versus Atenolol on Cardiovascular Morbidity and Mortality in Patients With Hypertension Taking Aspirin. Journal of the American College of Cardiology. 46(5). 770–775. 17 indexed citations
4.
Fossum, Eigil, Aud Høieggen, Henrik M. Reims, et al.. (2004). High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men. Blood Pressure. 13(2). 89–94. 22 indexed citations
5.
Fossum, Eigil, Knut Erik Berge, Aud Høieggen, et al.. (2001). Polymorphisms in Candidate Genes for Blood Pressure Regulation in Young Men with Normal or Elevated Screening Blood Pressure. Blood Pressure. 10(2). 92–100. 8 indexed citations
6.
Fossum, Eigil, Aud Høieggen, Andreas Moan, Morten Rostrup, & Sverre E. Kjeldsen. (1999). Insulin Sensitivity Is Related to Physical Fitness and Exercise Blood Pressure to Structural Vascular Properties in Young Men. Hypertension. 33(3). 781–786. 35 indexed citations
7.
Fossum, Eigil, et al.. (1998). Whole-blood viscosity and the insulin-resistance syndrome. Journal of Hypertension. 16(2). 203–210. 72 indexed citations
8.
Seljeflot, Ingebjørg, Andreas Moan, Trude Aspelin, et al.. (1998). Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo. Metabolism. 47(3). 292–296. 11 indexed citations
9.
Fossum, Eigil, et al.. (1997). Whole Blood Viscosity, Blood Pressure and Cardiovascular Risk Factors in Healthy Blood Donors. Blood Pressure. 6(3). 161–165. 47 indexed citations
10.
Moan, Andreas, et al.. (1996). Effects of Increased Arterial Epinephrine on Insulin, Glucose and Phosphate. Blood Pressure. 5(1). 27–31. 21 indexed citations
11.
Moan, Andreas, et al.. (1996). The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. Journal of Hypertension. 14(9). 1093–1097. 64 indexed citations
12.
Nordby, Gudmund, Andreas Moan, SE Kjeldsen, & Ingrid Os. (1995). Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. American Journal of Hypertension. 8(5). 439–444. 24 indexed citations
13.
Nordby, Gudmund, et al.. (1995). Insulin Resistance and Sympathetic Nervous System Activity in Hypertensive and Normotensive Premenopausal Women. Blood Pressure. 4(5). 287–292. 1 indexed citations
14.
Moan, Andreas, et al.. (1995). Hypertension Therapy and Risk of Coronary Heart Disease: How Do Antihypertensives Affect Metabolic Factors?. Cardiology. 86(2). 89–93. 4 indexed citations
15.
Moan, Andreas. (1995). Does hyperinsulinemia activate the sympathetic nervous system?. American Journal of Hypertension. 8(4). 58A–58A. 1 indexed citations
16.
Moan, Andreas, Gudmund Nordby, Ingrid Os, Kåre I. Birkeland, & Sverre E. Kjeldsen. (1994). Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism. 43(4). 423–427. 85 indexed citations
17.
18.
Kjeldsen, Sverre E., Andreas Moan, Jurij Pétrin, et al.. (1993). Evaluation of Self-Measured Home vs. Clinic Intra-Arterial Blood Pressure. Blood Pressure. 2(1). 28–34. 16 indexed citations
19.
Kjeldsen, Sverre E., et al.. (1992). The Sympathetic Nervous System May Modulate the Metabolic Cardiovascular Syndrome in Essential Hypertension. Journal of Cardiovascular Pharmacology. 20(Supplement 8). S32–S39. 34 indexed citations
20.
Kjeldsen, Sverre E., et al.. (1992). The Sympathetic Nervous System May Modulate the Metabolic Cardiovascular Syndrome in Essential Hypertension. Journal of Cardiovascular Pharmacology. 20(Supplement 8). S32–S39. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Arenare Breakdown of academic impact, for papers by Elena Cerquetani Breakdown of academic impact, for papers by Eiji Gotoh Breakdown of academic impact, for papers by Ciro Basile Fasolo Breakdown of academic impact, for papers by J. I. M. Drayer Breakdown of academic impact, for papers by SE Kjeldsen Breakdown of academic impact, for papers by Thomas Makris Breakdown of academic impact, for papers by H. Steinberg Breakdown of academic impact, for papers by A. C. Pessina Breakdown of academic impact, for papers by P. Lazzari
Rankless by CCL
2026